{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:18:21Z","timestamp":1789431501361,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["075-15-2020-899"],"award-info":[{"award-number":["075-15-2020-899"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.lpm.2021.104075","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T02:20:40Z","timestamp":1632277240000},"page":"104075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Generalized lipoatrophy syndromes"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7006-0664","authenticated-orcid":false,"given":"Ekaterina","family":"Sorkina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Chichkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.lpm.2021.104075_bib0001","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2021.104075_bib0002","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/DMSO.S130810","article-title":"Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges","volume":"10","author":"Chiquette","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"10.1016\/j.lpm.2021.104075_bib0003","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/liv.14430","article-title":"Redefining fatty liver disease classification in 2020","volume":"40","author":"Valenti","year":"2020","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.lpm.2021.104075_bib0004","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jmg.39.10.722","article-title":"Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy","volume":"39","author":"Van Maldergem","year":"2002","journal-title":"J Med Genet"},{"issue":"10","key":"10.1016\/j.lpm.2021.104075_bib0005","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1210\/jc.2003-030855","article-title":"Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy","volume":"88","author":"Agarwal","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.lpm.2021.104075_bib0006","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/jcem-14-2-193","article-title":"An undiagnosed endocrinometabolic syndrome: report of 2 cases","volume":"14","author":"Berardinelli","year":"1954","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104075_bib0007","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1651-2227.1959.tb16421.x","article-title":"Lipodystrophy and gigantism with associated endocrine manifestations; A new diencephalic syndrome?","volume":"48","author":"Seip","year":"1959","journal-title":"Acta Pediat"},{"issue":"1","key":"10.1016\/j.lpm.2021.104075_bib0008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/jhg.2013.107","article-title":"Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies","volume":"59","author":"Nolis","year":"2014","journal-title":"J Hum Genet"},{"issue":"9","key":"10.1016\/j.lpm.2021.104075_bib0009","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2015.123","article-title":"Congenital generalized lipodystrophies\u2013new insights into metabolic dysfunction","volume":"11","author":"Patni","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104075_bib0010","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"Serum adiponectin and leptin levels in patients with lipodystrophies","volume":"87","author":"Haque","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.lpm.2021.104075_bib0011","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1210\/jc.2009-1824","article-title":"Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency","volume":"95","author":"Antuna-Puente","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104075_bib0012","doi-asserted-by":"crossref","unstructured":"Letova E.K., Starkova N.T. Differential diagnosis of generalized lipodystrophy syndrome. Problems of Endocrinology.1993 Oct;39(5):33\u201336. doi: 10.14341\/PROBL11960-9100.","DOI":"10.14341\/probl11960"},{"issue":"1","key":"10.1016\/j.lpm.2021.104075_bib0013","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4158\/endp.19.1.v767575m65p5mr06","article-title":"American Association of Clinical Endocrinologists. The clinical approach to the detection of lipodystrophy - an AACE consensus statement","volume":"19","author":"Handelsman","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/j.lpm.2021.104075_bib0014","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mrrev.2019.03.005","article-title":"The worldwide mutational landscape of Berardinelli-Seip congenital lipodystrophy","volume":"781","author":"Craveiro Sarmento","year":"2019","journal-title":"Mutat Res"},{"key":"10.1016\/j.lpm.2021.104075_bib0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fendo.2020.00039","article-title":"Congenital Generalized Lipoatrophy (Berardinelli-Seip Syndrome) Type 1: description of Novel AGPAT2 Homozygous Variants Showing the Highly Heterogeneous Presentation of the Disease","volume":"11","author":"Ceccarini","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.lpm.2021.104075_bib0016","article-title":"Lipodystrophies: disorders of adipose tissue biology","volume":"1791","author":"Garg","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.lpm.2021.104075_bib0017","doi-asserted-by":"crossref","first-page":"D944","DOI":"10.2741\/Leung","article-title":"The structure and functions of human lysophosphatidic acid acyltransferases","volume":"6","author":"Leung","year":"2001","journal-title":"Front Biosci"},{"issue":"11","key":"10.1016\/j.lpm.2021.104075_bib0018","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.2337\/db12-0004","article-title":"Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations","volume":"61","author":"Subauste","year":"2012","journal-title":"Diabetes"},{"issue":"1\u20134","key":"10.1016\/j.lpm.2021.104075_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0090-6980(01)00110-1","article-title":"Lysophosphatidic acid synthesis and release","volume":"64","author":"Pag\u00e8s","year":"2001","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"5548","key":"10.1016\/j.lpm.2021.104075_bib0020","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1126\/science.1065323","article-title":"Lysophospholipids\u2013receptor revelations","volume":"294","author":"Hla","year":"2001","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.lpm.2021.104075_bib0021","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MD.0b013e3181e9442f","article-title":"Cardiomyopathy in congenital and acquired generalized lipodystrophy: a clinical assessment","volume":"89","author":"Lupsa","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lpm.2021.104075_bib0022","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13098-020-00538-y","article-title":"Leu124Serfs*26, a novel AGPAT2 mutation in congenital generalized lipodystrophy with early cardiovascular complications","volume":"12","author":"Montenegro Junior","year":"2020","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"10.1016\/j.lpm.2021.104075_bib0023","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pathol.2018.11.004","article-title":"Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease","volume":"51","author":"Hussain","year":"2019","journal-title":"Pathology"},{"issue":"6","key":"10.1016\/j.lpm.2021.104075_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199052","article-title":"Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy","volume":"13","author":"Lima","year":"2018","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.lpm.2021.104075_bib0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"BSCL Working Group. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13","volume":"28","author":"Magr\u00e9","year":"2001","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.lpm.2021.104075_bib0026","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.molmed.2004.07.009","article-title":"Seipin: a mysterious protein","volume":"10","author":"Agarwal","year":"2004","journal-title":"Trends Mol Med"},{"issue":"52","key":"10.1016\/j.lpm.2021.104075_bib0027","doi-asserted-by":"crossref","first-page":"20890","DOI":"10.1073\/pnas.0704154104","article-title":"The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology","volume":"104","author":"Szymanski","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"21","key":"10.1016\/j.lpm.2021.104075_bib0028","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.3390\/ijms21218208","article-title":"SEIPIN: a key factor for nuclear lipid droplet generation and lipid homeostasis","volume":"21","author":"Jin","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.lpm.2021.104075_bib0029","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1210\/jc.2003-030835","article-title":"Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes","volume":"88","author":"Simha","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.lpm.2021.104075_bib0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0014-5793(98)00619-X","article-title":"Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2\/7q31)","volume":"429","author":"Engelman","year":"1998","journal-title":"FEBS Lett"},{"issue":"11","key":"10.1016\/j.lpm.2021.104075_bib0031","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1172\/JCI200114611","article-title":"Caveolin-deficient mice: insights into caveolar function human disease","volume":"108","author":"Razani","year":"2001","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.lpm.2021.104075_bib0032","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.2337\/db13-1961","article-title":"Caveolin-1 expression and cavin stability regulate caveolae dynamics in adipocyte lipid store fluctuation","volume":"63","author":"Briand","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.lpm.2021.104075_bib0033","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy","volume":"93","author":"Kim","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.lpm.2021.104075_bib0034","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/ajmg.a.37115","article-title":"Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome","volume":"167A","author":"Garg","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"12","key":"10.1016\/j.lpm.2021.104075_bib0035","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/tra.12452","article-title":"Characterization of a caveolin-1 mutation associated with both pulmonary arterial hypertension and congenital generalized lipodystrophy","volume":"17","author":"Han","year":"2016","journal-title":"Traffic"},{"issue":"9","key":"10.1016\/j.lpm.2021.104075_bib0036","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy","volume":"119","author":"Hayashi","year":"2009","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.lpm.2021.104075_bib0037","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1582-4934.2008.00295.x","article-title":"Caveolae structure and function","volume":"12","author":"Thomas","year":"2008","journal-title":"J Cell Mol Med"},{"issue":"9","key":"10.1016\/j.lpm.2021.104075_bib0038","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/ajmg.a.33578","article-title":"Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations","volume":"152A","author":"Shastry","year":"2010","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/j.lpm.2021.104075_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000874","article-title":"Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations","volume":"6","author":"Rajab","year":"2010","journal-title":"PLoS Genet"},{"issue":"3","key":"10.1016\/j.lpm.2021.104075_bib0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajmg.10437","article-title":"Heterogeneity for congenital generalized lipodystrophy in seventeen patients from Oman","volume":"110","author":"Rajab","year":"2002","journal-title":"Am J Med Genet"},{"issue":"18","key":"10.1016\/j.lpm.2021.104075_bib0041","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/ajmg.a.32457","article-title":"Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability","volume":"146A","author":"Simha","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.lpm.2021.104075_bib0042","article-title":"Congenital generalized lipodystrophy: the evaluation of clinical follow-up findings in a series of five patients with type 1 and two patients with type 4","volume":"63","author":"G\u00fcne\u015f","year":"2020","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.lpm.2021.104075_bib0043","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40842-020-00095-3","article-title":"Unusual clinical features associated with congenital generalized lipodystrophy type 4 in a patient with a novel E211X CAVIN1 gene variant","volume":"6","author":"Sorkina","year":"2020","journal-title":"Clin Diabetes Endocrinol"},{"issue":"24","key":"10.1016\/j.lpm.2021.104075_bib0044","doi-asserted-by":"crossref","first-page":"8901","DOI":"10.1073\/pnas.1408523111","article-title":"Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease","volume":"111","author":"Payne","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"9","key":"10.1016\/j.lpm.2021.104075_bib0045","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ejmg.2014.06.006","article-title":"Biallelic mutations at PPARG cause a congenital, generalized lipodystrophy similar to the Berardinelli-Seip syndrome","volume":"57","author":"Dyment","year":"2014","journal-title":"Eur J Med Genet"},{"issue":"6","key":"10.1016\/j.lpm.2021.104075_bib0046","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/humu.20315","article-title":"A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS","volume":"27","author":"Denecke","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.lpm.2021.104075_bib0047","unstructured":"Fast Facts | Progeria Research Foundation. https:\/\/www.progeriaresearch.org\/quick-facts"},{"issue":"5259","key":"10.1016\/j.lpm.2021.104075_bib0048","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.272.5259.258","article-title":"Positional cloning of the Werner's syndrome gene","volume":"272","author":"Yu","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.lpm.2021.104075_bib0049","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1750-1172-8-106","article-title":"Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome","volume":"8","author":"Donadille","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.lpm.2021.104075_bib0050","first-page":"46","article-title":"Werner Syndrome","volume":"2","author":"Chen","year":"2002","journal-title":"J Biomed Biotechnol"},{"issue":"9382","key":"10.1016\/j.lpm.2021.104075_bib0051","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(03)14069-X","article-title":"LMNA mutations in atypical Werner's syndrome","volume":"362","author":"Chen","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.lpm.2021.104075_bib0052","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/jmg.2003.015651","article-title":"Novel lamin A\/C gene (LMNA) mutations in atypical progeroid syndromes","volume":"41","author":"Csoka","year":"2004","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.lpm.2021.104075_bib0053","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1210\/jc.2017-02078","article-title":"A novel generalized lipodystrophy-associated progeroid syndrome due to recurrent heterozygous LMNA p.T10I Mutation","volume":"103","author":"Hussain","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104075_bib0054","first-page":"20","article-title":"Atypical progeroid syndrome (p.E262K LMNA mutation): a rare cause of short stature and osteoporosis","volume":"2021","author":"Yukina","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.lpm.2021.104075_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2017.12.001","article-title":"Mandibuloacral dysplasia: a premature ageing disease with aspects of physiological ageing","volume":"42","author":"Cenni","year":"2018","journal-title":"Ageing Res Rev"},{"issue":"2","key":"10.1016\/j.lpm.2021.104075_bib0056","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1086\/341908","article-title":"Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A\/C","volume":"71","author":"Novelli","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"16","key":"10.1016\/j.lpm.2021.104075_bib0057","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/hmg\/ddg213","article-title":"Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia","volume":"12","author":"Agarwal","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.lpm.2021.104075_bib0058","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1210\/jc.2002-021575","article-title":"Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy","volume":"88","author":"Simha","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104075_bib0059","doi-asserted-by":"crossref","first-page":"256.","DOI":"10.1186\/1471-2431-14-256","article-title":"Mandibuloacral dysplasia type A-associated progeria caused by homozygous LMNA mutation in a family from Southern China","volume":"14","author":"Luo","year":"2014","journal-title":"BMC Pediatr"},{"issue":"8","key":"10.1016\/j.lpm.2021.104075_bib0060","doi-asserted-by":"crossref","DOI":"10.1038\/ng.2670","article-title":"An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy","volume":"45","author":"Weedon","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2021.104075_bib0061","doi-asserted-by":"crossref","first-page":"17031","DOI":"10.1038\/hgv.2017.31","article-title":"The first Japanese patient with mandibular hypoplasia, deafness, progeroid features and lipodystrophy diagnosed via POLD1 mutation detection","volume":"4","author":"Okada","year":"2017","journal-title":"Hum Genome Var"},{"issue":"16","key":"10.1016\/j.lpm.2021.104075_bib0062","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1097\/CM9.0000000000000986","article-title":"A Chinese girl with mandibular hypoplasia, deafness, progeroid features, and lipodystrophy (MDPL) diagnosed via POLD1 mutation detection","volume":"133","author":"Wang","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.lpm.2021.104075_bib0063","article-title":"A De Novo POLD1 mutation associated with mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome in a family with Werner syndrome","volume":"6","author":"Wang","year":"2018","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"11","key":"10.1016\/j.lpm.2021.104075_bib0064","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ng.3103","article-title":"Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features","volume":"46","author":"Lessel","year":"2014","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.lpm.2021.104075_bib0065","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/ajmg.a.61777","article-title":"An additional case of N\u00e9stor-Guillermo progeria syndrome diagnosed in early childhood","volume":"182","author":"Fisher","year":"2020","journal-title":"Am J Med Genet A"},{"issue":"11","key":"10.1016\/j.lpm.2021.104075_bib0066","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/ajmg.a.34249","article-title":"N\u00e9stor-Guillermo progeria syndrome: a novel premature aging condition with early onset and chronic development caused by BANF1 mutations","volume":"155A","author":"Cabanillas","year":"2011","journal-title":"Am J Med Genet A"},{"issue":"11","key":"10.1016\/j.lpm.2021.104075_bib0067","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1002\/ajmg.a.33690","article-title":"Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3\u2032 terminus of the FBN1-gene","volume":"152A","author":"Graul-Neumann","year":"2010","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.lpm.2021.104075_bib0068","doi-asserted-by":"crossref","first-page":"e1023","DOI":"10.1002\/mgg3.1023","article-title":"Deciphering Disorders Involving Scoliosis and COmorbidities (DISCO) study, Lupski JR, Wu Z, Zhang J, Wu N. Genetic and molecular mechanism for distinct clinical phenotypes conveyed by allelic truncating mutations implicated in FBN1","volume":"8","author":"Lin","year":"2020","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"10.1016\/j.lpm.2021.104075_bib0069","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ajhg.2014.12.011","article-title":"Keppen-Lubinsky syndrome is caused by mutations in the inwardly rectifying K+ channel encoded by KCNJ6","volume":"96","author":"Masotti","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"7","key":"10.1016\/j.lpm.2021.104075_bib0070","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/ajmg.a.38246","article-title":"Wiedemann-Rautenstrauch syndrome: a phenotype analysis","volume":"173","author":"Paolacci","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.lpm.2021.104075_bib0071","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","article-title":"PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy","volume":"93","author":"Thauvin-Robinet","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"6404","key":"10.1016\/j.lpm.2021.104075_bib0072","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(46)91599-1","article-title":"Lipodystrophy and hepatomegaly with diabetes, lipaemia, and other metabolic disturbances; a case throwing new light on the action of insulin. (concluded)","volume":"1","author":"Lawrence","year":"1946","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.lpm.2021.104075_bib0073","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ad.2011.08.006","article-title":"Late-onset acquired generalized lipodystrophy with muscle involvement","volume":"103","author":"Llamas-Velasco","year":"2012","journal-title":"Actas Dermosifiliogr"},{"issue":"2","key":"10.1016\/j.lpm.2021.104075_bib0074","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005792-200303000-00007","article-title":"Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature","volume":"82","author":"Misra","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.lpm.2021.104075_bib0075","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ecl.2016.06.012","article-title":"Lipodystrophy Syndromes","volume":"45","author":"Hussain","year":"2016","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"10.1016\/j.lpm.2021.104075_bib0076","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/DAD.0000000000000721","article-title":"Lipophagic panniculitis of childhood: a case report and comprehensive review of the literature","volume":"39","author":"Levy","year":"2017","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104075_bib0077","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2008-1703","article-title":"Complement abnormalities in acquired lipodystrophy revisited","volume":"94","author":"Savage","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.lpm.2021.104075_bib0078","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.lpm.2021.104075_bib0079","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13023-020-1295-y","article-title":"European lipodystrophy registry: background and structure","volume":"15","author":"von Schnurbein","year":"2020","journal-title":"Orphanet J Rare Dis"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:08:10Z","timestamp":1760105290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498221000142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0755498221000142"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104075","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generalized lipoatrophy syndromes","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104075"}}